Epilepsy is a major societal burden with a significant impact on patients' health and quality of life. The primary goal in epilepsy management is to achieve freedom from all types of seizures. Early treatment with antiseizure medications plays a crucial role in this regard, preventing seizure recurrence, limiting disease progression and comorbidities, and improving both prognosis and quality of life. However, initial treatment is typically managed by non-epilepsy specialists, and there are considerable gaps in care that need to be addressed. In order to support non-epilepsy experts in the initial management of uncontrolled epilepsy, we report here on the most significant challenges and obstacles encountered by non-epilepsy specialists in their daily clinical routine, based on literature evidence and outcomes from our recent survey of Spanish neurologists, and provide recommendations to improve patient care.
No takes yet. Share an insight, caveat, or question.
García‐Azorín et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: